Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
32 hedge funds and large institutions have $267M invested in Myovant Sciences Ltd. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 11 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
11% less funds holding
Funds holding: 36 → 32 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
57% less capital invested
Capital invested by funds: $628M → $267M (-$360M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.58M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$2.23M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$825K |
| 4 |
EU
Emory University
Atlanta,
Georgia
|
+$685K |
| 5 |
Millennium Management
New York
|
+$572K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$471M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.03M |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$1.27M |
| 5 |
SCM
Sio Capital Management
New York
|
-$923K |
MYOV Hedge Fund Activity: Q1 2018 in Review
32 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2018, worth a combined $267M — down 57% from $628M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of MYOV and 7 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 12 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $6.58M. The largest seller was QVT Financial, exiting entirely with an estimated $471M sold.
- 32 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2018, down from 36 in Q4 2017.
- Funds reported $267M of Myovant Sciences Ltd. stock for Q1 2018, down 57% quarter-over-quarter.
- 7 funds opened new Myovant Sciences Ltd. positions in Q1 2018 and 11 closed out, a net change of -4 holders.
- The largest Myovant Sciences Ltd. buyer in Q1 2018 was T. Rowe Price Associates, an estimated $6.58M added.
- The largest Myovant Sciences Ltd. seller in Q1 2018 was QVT Financial, an estimated $471M sold.
Based on aggregated 13F filings for Q1 2018.